Related Experiment Video
Updated: May 13, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Role of bad in podocyte apoptosis induced by puromycin aminonucleoside
1Department of Core Laboratory, GuangZhou Medical University, Guangzhou first people hospital, China. Shengyouyu@163.com
Abstract:
Apoptosis, which is usually a response to the microenvironment, requires inactivation of prosurvival molecules. Apoptosis contributes to loss of podocytes in the course of renal injury, an event closely associated with the development of proteinuria. Dexamethasone (DEX) is the standard of care for most forms of nephrotic syndrome. However, the precise mechanisms of DEX action on podocytes are unknown. This study examined the hypothesis that cultured podocytes exposed to puromycin aminonucleoside (PAN) showed a reduced rate of apoptosis upon DEX exposure. Apoptotic podocytes seemed to be related to increased Bad mRNA and protein expressions. DEX reduced apoptosis by decreasing Bad mRNA and protein expressions, thereby protecting podocytes. These findings provided insights into the beneficial effects of DEX directly on podocytes. The present study illustrated the signal transduction mechanism of podocyte apoptosis induced by PAN.
Insights
Dexamethasone (DEX) reduces podocyte apoptosis in kidney injury by decreasing Bad protein expression. This finding reveals DEX’s protective mechanism against proteinuria in nephrotic syndrome.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Apoptosis, or programmed cell death, contributes to podocyte loss in renal injury, leading to proteinuria.
- Dexamethasone (DEX) is a primary treatment for nephrotic syndrome, but its effects on podocytes are not fully understood.
Purpose of the Study:
- To investigate the protective mechanisms of DEX against apoptosis in cultured podocytes.
- To elucidate the role of Bad protein in DEX-mediated podocyte protection.
Main Methods:
- Cultured podocytes were exposed to puromycin aminonucleoside (PAN) to induce apoptosis.
- DEX treatment was administered to assess its effect on apoptosis rates.
- Messenger RNA (mRNA) and protein expression levels of Bad were analyzed.
Main Results:
- Puromycin aminonucleoside (PAN) exposure increased Bad mRNA and protein expression, inducing podocyte apoptosis.
- Dexamethasone (DEX) significantly reduced podocyte apoptosis.
- DEX decreased both Bad mRNA and protein levels in podocytes.
Conclusions:
- Dexamethasone (DEX) protects podocytes from apoptosis, likely by downregulating Bad expression.
- These findings offer insights into the direct cellular mechanisms underlying DEX's therapeutic effects in nephrotic syndrome.
- The study clarifies the signal transduction pathway of podocyte apoptosis induced by PAN.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Acute Kidney Injury II: Pathophysiology

